BMPR1A

Bone morphogenetic protein receptor
BMPR1A
Available structures
PDBOrtholog search: PDBe RCSB
List of PDB id codes

3QB4, 1ES7, 1REW, 2GOO, 2H62, 2H64, 2K3G, 2QJ9, 2QJA, 2QJB, 3NH7

Identifiers
AliasesBMPR1A, 10q23del, ACVRLK3, ALK3, CD292, SKR5, bone morphogenetic protein receptor type 1A
External IDsOMIM: 601299 MGI: 1338938 HomoloGene: 20911 GeneCards: BMPR1A
Gene location (Human)
Chromosome 10 (human)
Chr.Chromosome 10 (human)[1]
Chromosome 10 (human)
Genomic location for BMPR1A
Genomic location for BMPR1A
Band10q23.2Start86,756,601 bp[1]
End86,932,825 bp[1]
Gene location (Mouse)
Chromosome 14 (mouse)
Chr.Chromosome 14 (mouse)[2]
Chromosome 14 (mouse)
Genomic location for BMPR1A
Genomic location for BMPR1A
Band14 B|14 20.81 cMStart34,132,691 bp[2]
End34,225,298 bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • secondary oocyte

  • Achilles tendon

  • saphenous vein

  • parotid gland

  • biceps brachii

  • seminal vesicula

  • popliteal artery

  • urethra

  • hair follicle

  • tibia
Top expressed in
  • ascending aorta

  • aortic valve

  • vas deferens

  • calvaria

  • iris

  • ciliary body

  • hair follicle

  • Paneth cell

  • maxillary prominence

  • foot
More reference expression data
BioGPS


More reference expression data
Gene ontology
Molecular function
  • transferase activity
  • nucleotide binding
  • protein kinase activity
  • protein homodimerization activity
  • metal ion binding
  • kinase activity
  • protein serine/threonine kinase activity
  • transmembrane receptor protein serine/threonine kinase activity
  • protein binding
  • DNA-binding transcription factor activity, RNA polymerase II-specific
  • SMAD binding
  • ATP binding
  • BMP receptor activity
  • transforming growth factor beta-activated receptor activity
  • transforming growth factor beta receptor activity, type I
  • growth factor binding
Cellular component
  • integral component of membrane
  • HFE-transferrin receptor complex
  • membrane
  • plasma membrane
  • neuronal cell body
  • dendrite
  • caveola
  • external side of plasma membrane
  • integral component of plasma membrane
  • receptor complex
  • cell surface
Biological process
  • somitogenesis
  • pattern specification process
  • roof of mouth development
  • cell differentiation
  • pituitary gland development
  • endoderm development
  • chondrocyte differentiation
  • neural crest cell development
  • lateral mesoderm development
  • lung development
  • positive regulation of bone mineralization
  • embryonic organ development
  • paraxial mesoderm structural organization
  • positive regulation of epithelial cell proliferation
  • phosphorylation
  • negative regulation of neurogenesis
  • positive regulation of pathway-restricted SMAD protein phosphorylation
  • mesoderm formation
  • ectoderm development
  • embryonic digit morphogenesis
  • heart morphogenesis
  • cellular response to BMP stimulus
  • in utero embryonic development
  • BMP signaling pathway
  • hindlimb morphogenesis
  • nervous system development
  • dorsal/ventral axis specification
  • regulation of lateral mesodermal cell fate specification
  • stem cell population maintenance
  • odontogenesis of dentin-containing tooth
  • Mullerian duct regression
  • endocardial cushion formation
  • protein phosphorylation
  • positive regulation of transcription, DNA-templated
  • heart development
  • cartilage development
  • positive regulation of osteoblast differentiation
  • developmental growth
  • transmembrane receptor protein serine/threonine kinase signaling pathway
  • positive regulation of mesenchymal cell proliferation
  • heart formation
  • neural plate pattern specification
  • embryonic morphogenesis
  • mesendoderm development
  • immune response
  • regulation of cellular senescence
  • neural plate mediolateral regionalization
  • dorsal/ventral pattern formation
  • transforming growth factor beta receptor signaling pathway
  • positive regulation of SMAD protein signal transduction
  • anterior/posterior pattern specification
  • paraxial mesoderm development
  • positive regulation of pri-miRNA transcription by RNA polymerase II
  • negative regulation of smooth muscle cell migration
  • BMP signaling pathway involved in heart development
  • regulation of cardiac muscle cell apoptotic process
  • outflow tract septum morphogenesis
  • outflow tract morphogenesis
  • cardiac conduction system development
  • mitral valve morphogenesis
  • tricuspid valve morphogenesis
  • endocardial cushion morphogenesis
  • cardiac right ventricle morphogenesis
  • ventricular trabecula myocardium morphogenesis
  • ventricular compact myocardium morphogenesis
  • dorsal aorta morphogenesis
  • positive regulation of transcription by RNA polymerase II
  • regulation of cardiac muscle cell proliferation
  • positive regulation of cardiac muscle cell proliferation
  • pharyngeal arch artery morphogenesis
  • positive regulation of cardiac ventricle development
  • positive regulation of vascular associated smooth muscle cell proliferation
  • fibrous ring of heart morphogenesis
  • regulation of neural crest cell differentiation
Sources:Amigo / QuickGO
Orthologs
SpeciesHumanMouse
Entrez

657

12166

Ensembl

ENSG00000107779

ENSMUSG00000021796

UniProt

P36894

P36895

RefSeq (mRNA)

NM_004329

NM_009758

RefSeq (protein)

NP_004320

NP_033888

Location (UCSC)Chr 10: 86.76 – 86.93 MbChr 14: 34.13 – 34.23 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

The bone morphogenetic protein receptor, type IA also known as BMPR1A is a protein which in humans is encoded by the BMPR1A gene. BMPR1A has also been designated as CD292 (cluster of differentiation 292).[5]

Function

The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A (this protein) and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF beta superfamily. TGF-betas and activins transduce their signals through the formation of heterodimeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding.[5]

BMP's repress WNT signaling to maintain stable stem cell populations. BMPR1A null mice died at embryonic day 8.0 without mesoderm specification, demonstrating its vital role in gastrulation.[6] It has been demonstrated in experiments using dominant negative BMPR1A chick embryos that BMPR1A plays a role in apoptosis and adipocyte development.[6] Using constitutively active forms of BMPR1A, it has been shown that BMPR1A plays a role in cell differentiation.[6] Signals transduced by the BMPR1A receptor are not essential for osteoblast formation or proliferation; however, BMPR1A is necessary for the extracellular matrix deposition by osteoblasts.[6] In the chick embryo, BMPR1A receptors are found in low levels in limb bud mesenchyme, a differing location to BMPR1B, supporting the differing roles they play in osteogenesis.[7]

Ligands

Diseases

BMPR1A, SMAD4 and PTEN are responsible for juvenile polyposis syndrome, juvenile intestinal polyposis and Cowden's disease.

Interactions

BMPR1A has been shown to interact with:

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000107779 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000021796 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b "Entrez Gene: BMPR1A bone morphogenetic protein receptor, type IA".
  6. ^ a b c d Mishina Y, Starbuck MW, Gentile MA, Fukuda T, Kasparcova V, Seedor JG, Hanks MC, Amling M, Pinero GJ, Harada S, Behringer RR (2004). "Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling". J. Biol. Chem. 279 (26): 27560–6. doi:10.1074/jbc.M404222200. PMID 15090551.
  7. ^ Yoon BS, Ovchinnikov DA, Yoshii I, Mishina Y, Behringer RR, Lyons KM (2005). "Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo". Proc. Natl. Acad. Sci. U.S.A. 102 (14): 5062–7. Bibcode:2005PNAS..102.5062Y. doi:10.1073/pnas.0500031102. PMC 555995. PMID 15781876.
  8. ^ Nickel J, Dreyer MK, Kirsch T, Sebald W (2001). "The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists". J Bone Joint Surg Am. 83-A Suppl 1 (Pt 1): S7–14. PMID 11263668.
  9. ^ Kirsch T, Nickel J, Sebald W (February 2000). "Isolation of recombinant BMP receptor IA ectodomain and its 2:1 complex with BMP-2". FEBS Lett. 468 (2–3): 215–9. doi:10.1016/s0014-5793(00)01214-x. PMID 10692589. S2CID 30068719.
  10. ^ Kirsch T, Nickel J, Sebald W (July 2000). "BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II". EMBO J. 19 (13): 3314–24. doi:10.1093/emboj/19.13.3314. PMC 313944. PMID 10880444.
  11. ^ Gilboa L, Nohe A, Geissendörfer T, Sebald W, Henis YI, Knaus P (March 2000). "Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors". Mol. Biol. Cell. 11 (3): 1023–35. doi:10.1091/mbc.11.3.1023. PMC 14828. PMID 10712517.
  12. ^ Nishanian TG, Waldman T (October 2004). "Interaction of the BMPR-IA tumor suppressor with a developmentally relevant splicing factor". Biochem. Biophys. Res. Commun. 323 (1): 91–7. doi:10.1016/j.bbrc.2004.08.060. PMID 15351706.
  13. ^ Kurozumi K, Nishita M, Yamaguchi K, Fujita T, Ueno N, Shibuya H (April 1998). "BRAM1, a BMP receptor-associated molecule involved in BMP signalling". Genes Cells. 3 (4): 257–64. doi:10.1046/j.1365-2443.1998.00186.x. PMID 9663660. S2CID 29818690.

Further reading

  • Liu F, Ventura F, Doody J, Massagué J (1995). "Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs". Mol. Cell. Biol. 15 (7): 3479–86. doi:10.1128/mcb.15.7.3479. PMC 230584. PMID 7791754.
  • ten Dijke P, Ichijo H, Franzén P, Schulz P, Saras J, Toyoshima H, Heldin CH, Miyazono K (1993). "Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity". Oncogene. 8 (10): 2879–87. PMID 8397373.
  • Ishidou Y, Kitajima I, Obama H, Maruyama I, Murata F, Imamura T, Yamada N, ten Dijke P, Miyazono K, Sakou T (1996). "Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation". J. Bone Miner. Res. 10 (11): 1651–9. doi:10.1002/jbmr.5650101107. PMID 8592941. S2CID 33345688.
  • Yamada N, Kato M, ten Dijke P, Yamashita H, Sampath TK, Heldin CH, Miyazono K, Funa K (1996). "Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours". Br. J. Cancer. 73 (5): 624–9. doi:10.1038/bjc.1996.108. PMC 2074358. PMID 8605097.
  • Nishitoh H, Ichijo H, Kimura M, Matsumoto T, Makishima F, Yamaguchi A, Yamashita H, Enomoto S, Miyazono K (1996). "Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5". J. Biol. Chem. 271 (35): 21345–52. doi:10.1074/jbc.271.35.21345. PMID 8702914.
  • Wu X, Robinson CE, Fong HW, Gimble JM (1996). "Analysis of the native murine bone morphogenetic protein serine threonine kinase type I receptor (ALK-3)". J. Cell. Physiol. 168 (2): 453–61. doi:10.1002/(SICI)1097-4652(199608)168:2<453::AID-JCP24>3.0.CO;2-2. PMID 8707881. S2CID 22669576.
  • Erlacher L, McCartney J, Piek E, ten Dijke P, Yanagishita M, Oppermann H, Luyten FP (1998). "Cartilage-derived morphogenetic proteins and osteogenic protein-1 differentially regulate osteogenesis". J. Bone Miner. Res. 13 (3): 383–92. doi:10.1359/jbmr.1998.13.3.383. PMID 9525338. S2CID 25307046.
  • Zhang D, Mehler MF, Song Q, Kessler JA (1998). "Development of bone morphogenetic protein receptors in the nervous system and possible roles in regulating trkC expression". J. Neurosci. 18 (9): 3314–26. doi:10.1523/JNEUROSCI.18-09-03314.1998. PMC 6792660. PMID 9547239.
  • Ide H, Saito-Ohara F, Ohnami S, Osada Y, Ikeuchi T, Yoshida T, Terada M (1998). "Assignment of the BMPR1A and BMPR1B genes to human chromosome 10q22.3 and 4q23→q24 byin situ hybridization and radiation hybrid map ping". Cytogenet. Cell Genet. 81 (3–4): 285–6. doi:10.1159/000015048. PMID 9730621. S2CID 46751090.
  • Souchelnytskyi S, Nakayama T, Nakao A, Morén A, Heldin CH, Christian JL, ten Dijke P (1998). "Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-beta receptors". J. Biol. Chem. 273 (39): 25364–70. doi:10.1074/jbc.273.39.25364. PMID 9738003.
  • You L, Kruse FE, Pohl J, Völcker HE (1999). "Bone morphogenetic proteins and growth and differentiation factors in the human cornea". Invest. Ophthalmol. Vis. Sci. 40 (2): 296–311. PMID 9950587.
  • Aström AK, Jin D, Imamura T, Röijer E, Rosenzweig B, Miyazono K, ten Dijke P, Stenman G (1999). "Chromosomal localization of three human genes encoding bone morphogenetic protein receptors". Mamm. Genome. 10 (3): 299–302. doi:10.1007/s003359900990. PMID 10051328. S2CID 19132542.
  • Ebisawa T, Tada K, Kitajima I, Tojo K, Sampath TK, Kawabata M, Miyazono K, Imamura T (2000). "Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation". J. Cell Sci. 112 (20): 3519–27. doi:10.1242/jcs.112.20.3519. PMID 10504300.
  • Kim IY, Lee DH, Ahn HJ, Tokunaga H, Song W, Devereaux LM, Jin D, Sampath TK, Morton RA (2000). "Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues". Cancer Res. 60 (11): 2840–4. PMID 10850425.
  • Kirsch T, Sebald W, Dreyer MK (2000). "Crystal structure of the BMP-2-BRIA ectodomain complex". Nat. Struct. Biol. 7 (6): 492–6. doi:10.1038/75903. PMID 10881198. S2CID 19403233.
  • Wan M, Shi X, Feng X, Cao X (2001). "Transcriptional mechanisms of bone morphogenetic protein-induced osteoprotegrin gene expression". J. Biol. Chem. 276 (13): 10119–25. doi:10.1074/jbc.M006918200. PMID 11139569.

External links

  • GeneReviews/NCBI/NIH/UW entry on Juvenile Polyposis Syndrome
  • BMPR1A+protein,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
  • Human BMPR1A genome location and BMPR1A gene details page in the UCSC Genome Browser.
  • v
  • t
  • e
  • 1es7: COMPLEX BETWEEN BMP-2 AND TWO BMP RECEPTOR IA ECTODOMAINS
    1es7: COMPLEX BETWEEN BMP-2 AND TWO BMP RECEPTOR IA ECTODOMAINS
  • 1rew: Structural refinement of the complex of bone morphogenetic protein 2 and its type IA receptor
    1rew: Structural refinement of the complex of bone morphogenetic protein 2 and its type IA receptor
  • 2goo: Ternary Complex of BMP-2 bound to BMPR-Ia-ECD and ActRII-ECD
    2goo: Ternary Complex of BMP-2 bound to BMPR-Ia-ECD and ActRII-ECD
  • 2h62: Crystal structure of a ternary ligand-receptor complex of BMP-2
    2h62: Crystal structure of a ternary ligand-receptor complex of BMP-2
  • 2h64: Crystal structure of a ternary ligand-receptor complex of BMP-2
    2h64: Crystal structure of a ternary ligand-receptor complex of BMP-2
  • v
  • t
  • e
1–50
51–100
101–150
151–200
201–250
251–300
301–350
  • v
  • t
  • e
TGF beta superfamily of ligands
Ligand of ACVR or TGFBR
Ligand of BMPR
TGF beta receptors
(Activin, BMP, family)
TGFBR1:
TGFBR2:
TGFBR3:
Transducers/SMAD
Ligand inhibitors
Coreceptors
Other
  • v
  • t
  • e
Non-specific serine/threonine protein kinases (EC 2.7.11.1)
Pyruvate dehydrogenase kinase (EC 2.7.11.2)
Dephospho-(reductase kinase) kinase (EC 2.7.11.3)
3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring) kinase (EC 2.7.11.4)
(isocitrate dehydrogenase (NADP+)) kinase (EC 2.7.11.5)
(tyrosine 3-monooxygenase) kinase (EC 2.7.11.6)
Myosin-heavy-chain kinase (EC 2.7.11.7)
Fas-activated serine/threonine kinase (EC 2.7.11.8)
Goodpasture-antigen-binding protein kinase (EC 2.7.11.9)
  • -
IκB kinase (EC 2.7.11.10)
cAMP-dependent protein kinase (EC 2.7.11.11)
cGMP-dependent protein kinase (EC 2.7.11.12)
Protein kinase C (EC 2.7.11.13)
Rhodopsin kinase (EC 2.7.11.14)
Beta adrenergic receptor kinase (EC 2.7.11.15)
G-protein coupled receptor kinases (EC 2.7.11.16)
Ca2+/calmodulin-dependent (EC 2.7.11.17)
Myosin light-chain kinase (EC 2.7.11.18)
Phosphorylase kinase (EC 2.7.11.19)
Elongation factor 2 kinase (EC 2.7.11.20)
Polo kinase (EC 2.7.11.21)
Serine/threonine-specific protein kinases (EC 2.7.11.21-EC 2.7.11.30)
Polo kinase (EC 2.7.11.21)
Cyclin-dependent kinase (EC 2.7.11.22)
(RNA-polymerase)-subunit kinase (EC 2.7.11.23)
Mitogen-activated protein kinase (EC 2.7.11.24)
MAP3K (EC 2.7.11.25)
Tau-protein kinase (EC 2.7.11.26)
(acetyl-CoA carboxylase) kinase (EC 2.7.11.27)
  • -
Tropomyosin kinase (EC 2.7.11.28)
  • -
Low-density-lipoprotein receptor kinase (EC 2.7.11.29)
  • -
Receptor protein serine/threonine kinase (EC 2.7.11.30)
MAP2K
  • v
  • t
  • e
TGFβ receptor superfamily modulators
Type I
ALK1 (ACVRL1)
  • Kinase inhibitors: K-02288
  • ML-347 (LDN-193719, VU0469381)
  • Other inhibitors: Disitertide
ALK2 (ACVR1A)
  • Kinase inhibitors: DMH-1
  • DMH-2
  • Dorsomorphin (BML-275)
  • K-02288
  • ML-347 (LDN-193719, VU0469381)
ALK3 (BMPR1A)
  • Kinase inhibitors: DMH-2
  • Dorsomorphin (BML-275)
  • K-02288
ALK4 (ACVR1B)
  • Kinase inhibitors: A 83-01
  • SB-431542
  • SB-505124
ALK5 (TGFβR1)
ALK6 (BMPR1B)
  • Kinase inhibitors: DMH-2
  • Dorsomorphin (BML-275)
  • K-02288
ALK7 (ACVR1C)
  • Antagonists: Lefty (1, 2)
  • Kinase inhibitors: A 83-01
  • SB-431542
  • SB-505124
Type II
TGFβR2
  • Kinase inhibitors: DMH-2
  • LY-364947
BMPR2
ACVR2A (ACVR2)
ACVR2B
  • Decoy receptors: Ramatercept
AMHR2 (AMHR)
Type III
TGFβR3 (β-glycan)
Unsorted
Portal:
  • icon Biology